Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Discover how the breakthrough pill orforglipron matches injectable weight loss drugs in effectiveness while offering ...

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...

Here is a round-up of the lesser-known side effects from taking semaglutide and tirzepatide weight loss injectables such as ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Advanced high-field MRI reveals distinct microstructural changes in hypothalamic subregions of young women with anorexia ...

Recently, researchers used modern laser microscopy techniques to observe how fluctuations in ovarian hormones shape both the structure and function of neurons in the mouse hippocampus, a brain ...

Given the scope of the risk, attention has turned to metabolic hormones that regulate appetite, satiety, and glucose metabolism, particularly glucagon-like peptide-1 (GLP-1). Its appetite ...

Here we present the crystal structure of the glycosylated dimerized hormone-binding domain of the ANP receptor at 2.0-Å resolution. The monomer comprises two interconnected subdomains ...